Micrus Endovascular Corp.’s (MEND) share price has entered into oversold territory with a stochastic value of 16.44. The Zacks Consensus Estimate on the company’s earnings for the year ending March 2011 has increased by a penny over the past month to 76 cents per share. Micrus Endovascular is a Zacks #2 Rank (“Buy”) company.
“MEND” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research